BCL2L1 and lymphoma: However, BCL6 inhibition also activates BCL6 target genes such as BCL2 and BCL2L1 (BCL-XL), and secondary MCL1, which can sustain lymphoma survival by suppressing the activity of pro-apoptotic BH3 proteins.